相关实验视频
Updated: Jul 4, 2025

09:59
Preparation of Exosomes for siRNA Delivery to Cancer Cells
Published on: December 5, 2018
25.1K
由Brucea javanica衍生出来的外体样纳米微粒可以为癌症治疗提供miRNA
Ge Yan1, Qiyao Xiao1, Jingyu Zhao1
1College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, PR China.
概括
药用植物衍生纳米纤维 (BF-Exos) 显示出治疗三阴性乳腺癌 (TNBC) 的前景. 这些纳米纤维提供微RNA来抑制癌症生长,转移和血管生成,提供一种潜在的新疗法.
科学领域:
- 生物技术是生物技术.
- 纳米医学是一种纳米医学.
- 癌症研究 癌症研究
背景情况:
- 三重阴性乳腺癌 (TNBC) 由于其异质性和缺乏向受体,因此存在重大治疗挑战.
- 化疗仍然是主要的治疗方法,但迫切需要新的治疗策略.
研究的目的:
- 在TNBC中研究来自B. javanica (BF-Exos) 的外体样纳米丝的治疗潜力.
- 阐明BF-Exos在抑制TNBC进展中的潜在分子机制.
主要方法:
- 从B. javanica.中分离和描述BF-Exos的特征.
- 使用4T1 TNBC细胞进行体外研究,以评估miRNA输送和细胞效应.
- 在小鼠模型中进行体内研究,以评估瘤生长,转移和血管新生抑制.
主要成果:
- BF-Exos向4T1细胞输送了功能性微RNA,显著抑制了细胞生长和转移.
- BF-Exos调节PI3K/Akt/mTOR通路,诱导ROS/酶介导的亡,并抑制血管内皮生长因子的分泌.
- 在体内,BF-Exos表现出强大的抗瘤,抗转移和抗血管新生效应,具有高生物安全性.
结论:
- BF-Exos代表了一种有前途的纳米平台,用于为TNBC治疗提供植物衍生核酸.
- 作为治疗三阴性乳腺癌的新生物疗法,BF-Exos具有显著的潜力.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Small interfering RNAs (siRNA)
3.5K
3.5K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K

